Abstract
The uroprotectant thiol mesna was found to protect adult CD-1 mice from high-dose cisplatin lethality. Mesna doses of 50 mg/kg were given with cisplatin, or 5 min after cisplatin (25 or 30 mg/kg) and acute survival was increased in non-tumor-bearing mice. In contrast, mesna mixed directly with cisplatin significantly reduced cisplatin antitumor effects in DBA/2J mice given 106 P-388 leukemia i.p. Mesna administered i.p. 5 min after cisplatin (6,8 or 10 mg/kg) did not reduce cisplatins' antitumor efficacy in this same tumor model. Mesna appears to inactivate cisplatin directly in vitro but possibly not in vivo if separate injections are used.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 604-605 |
| Number of pages | 2 |
| Journal | Journal of Cancer Research and Clinical Oncology |
| Volume | 115 |
| Issue number | 6 |
| DOIs | |
| State | Published - Nov 1989 |
Keywords
- Cisplatin
- Mesna
- Mice
ASJC Scopus subject areas
- Oncology
- Cancer Research